抑制剂

O-[(5-氨基-2-苯基-7-苯并噁唑基)甲基]-3,5-二氯-L-酪氨酸

O-[(5-Amino-2-phenyl-7-benzoxazolyl)methyl]-3,5-dichloro-L-tyrosine

- - 95%+

4-(6-甲基喹啉-2-基)苯磺酰胺

4-(6-Methylquinolin-2-yl)benzenesulfonamide

- - 95%+

2-(1,3-苯并二氧杂环戊烯-5-基)-6-甲氧基喹啉

2-(1,3-Benzodioxol-5-yl)-6-methoxyquinoline

- - 95%+

2-(1,3-苯并二氧杂环戊烯-5-基)-1,2,3,4-四氢-6-甲氧基喹啉

2-(1,3-Benzodioxol-5-yl)-1,2,3,4-tetrahydro-6-methoxyquinoline

- - 95%+

2-甲基-N6-(2-(3,4,5-三甲氧基苯基)噻吩并[3,2-d]嘧啶-4-基)喹啉-4,6-二胺

2-methyl-N6-(2-(3,4,5-trimethoxyphenyl)thieno[3,2-d]pyrimidin-4-yl)quinoline-4,6-diamine

- - 95%+

2-氨基-1-[(4-氟苯基)甲基]-1H-吡咯并[2,3-b]喹喔啉-3-羧酸甲酯

Methyl 2-amino-1-[(4-fluorophenyl)methyl]-1H-pyrrolo[2,3-b]quinoxaline-3-carboxylate

- - 95%+

Clifutinib

Clifutinib

- - 95%+

3-氰基-5-[2-[4-[2-(3-甲基吲哚-1-基)乙基]哌嗪-1-基]苯基]-N-(3-吡咯烷-1-基丙基)苯甲酰胺

3-Cyano-5-[2-[4-[2-(3-methylindol-1-yl)ethyl]piperazin-1-yl]phenyl]-N-(3-pyrrolidin-1-ylpropyl)benzamide

- - 95%+

4-[[2-[3-(1-甲基乙基)-4-(2-甲基丙氧基)-6-氧代-1(6H)-吡啶嗪基]乙酰基]氨基]-双环[2.1.1]己烷-1-甲酸甲酯

4-[[2-[3-(1-methylethyl)-4-(2-methylpropoxy)-6-oxo-1(6H)-pyridazinyl]acetyl]amino]- Bicyclo[2.1.1]hexane-1-carboxylic acid methyl ester

- - 95%+

帕罗伐汀

Palovarotene

- - 95%+

BAY 60-2770

Benzoic acid, 4-​[[(4-​carboxybutyl)​[2-​[5-​fluoro-​2-​[[4'-​(trifluoromethyl)​[1,​1'-​biphenyl]​-​4-​yl]​methoxy]​phenyl]​ethyl]​amino]​methyl]​-

- -

(3S)-3-(4-氯-3-[[(2S,3R)-2-(4-氯苯基)-4,4-4-三氟-3-甲基丁酰基]氨基]苯基)-3-环丙基丙酸

4-chloro-3-[[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methyl-1-oxobutyl]amino]-cyclopropyl-(S)-Benzenepropanoic acid

- -